Acarbose improves glycemic control as add-on or monotherapy in Indian type-2 diabetes: Findings from the GlucoVIP multinational observational study.

Add to Collection

2013 Dec Observational studies E Philip, ML Sundaram, R Das… - Indian Journal of …, 2013 - ncbi.nlm.nih.gov 100

Full Author : ['Philip, Elizabeth', 'Sundaram, Meenakshi L', 'Das, Rupam', 'Chauhan, Sushil Kumar', 'Deshpande, Sandeep', 'Ambhore, Sanjay', 'Rathod, Rahul', 'Manjrekar, Pravin']
Journal Title : Indian journal of endocrinology and metabolism
Chapter : Section4
Journal Year : 2013
Cited by : 9

OBJECTIVE: To investigate the efficacy and tolerability of the anti-diabetic agent acarbose (Glucobay((R))) as add-on or monotherapy in a range of patients with type-2 diabetes mellitus (T2DM), including those with cardiovascular morbidities in India. MAT..... Read More

Keywords : ['glucovip multinational observational study', 'acarbose improve glycemic control', 'indian diabete finding', 'monotherapy', 'addon']
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046615/
Google Scholar Link : https://scholar.google.com/scholar?cites=18076514176477160975&as_sdt=2005&sciodt=0,5&hl=en&num=20

Have a Question?

Acarbose improves glycemic control as add-on or monotherapy in Indian type-2 diabetes: Findings from the GlucoVIP multinational observational study.